Skip to main content
Fig. 2 | BMC Medical Research Methodology

Fig. 2

From: A plea for taking all available clinical information into account when assessing the predictive value of omics data

Fig. 2

Results on the validation part of Hatzis data. IBS values (a) for the clinical and the combined models and the differences (b) between the models as evaluated on the validation data set. C-index values (c) for the clinical and the combined models and the differences (d) between the models as evaluated on the validation data set. The gray squares indicate the values of the models developed on the whole training data set, whereas the boxplots indicate the values obtained from the subsampling analysis

Back to article page